Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Novonesis AS Share Issue/Capital Change 2017

Jan 24, 2017

Preview isn't available for this file type.

Download source file

On January 25, 2017, Novozymes will initiate a stock buyback program as
announced in Company announcement No. 1 of January 18, 2017. Under the program
Novozymes will buy back B shares worth up to DKK 2 billion in total during the
remainder of 2017, corresponding to around 8.1 million B shares at the current
share price. The program is contingent upon no major strategic initiatives
being decided upon that will require a significant amount of capital, for
example a major acquisition.

Read the full announcement in PDF